Persistence of the latent viral reservoir has been recognized as a major obstacle to eradicating human immunodeficiency virus (HIV) in infected individuals receiving antiretroviral therapy. It has been suggested that histone deacetylase inhibi-tors (HDACis) may purge HIV in the latent viral reservoir. However, the effect of HDACis on the degree and extent of HIV expression in the latent viral reservoir has not been fully delineated. Here we demonstrate that HDACis do not induce HIV production in the latent viral reservoir of aviremic indi-viduals. Therefore, alternative therapeutic strategies may be necessary to eliminate HIV in the latent viral reservoir. The majority of individuals infected with human immunodefi-ciency virus (HIV) receivi...
Background While antiretroviral therapies have improved life expectancy and reduced viral loads in ...
Resting memory CD4[superscript +] T-cells harboring latent HIV proviruses represent a critical barri...
Histone deacetylases (HDACs) act on histones within the nucleosome-bound promoter of human immunodef...
A reservoir of latently infected memory CD4(+) T cells is believed to be the source of HIV-1 reemerg...
Contains fulltext : 96985.pdf (publisher's version ) (Open Access)A reservoir of l...
Abstract Recently, there is considerable interest in the field of anti-HIV therapy to identify and d...
Silencing of the integrated human immunodeficiency virus type 1 (HIV-1) genome in resting CD4+ T cel...
Objectives: The latent reservoir for HIV-1 in resting memory CD4+ T cells is a major barrier to erad...
© 2014 Elliott et al.Human immunodeficiency virus (HIV) persistence in latently infected resting mem...
<div><p>Resting memory CD4<sup>+</sup> T-cells harboring latent HIV proviruses represent a critical ...
Interest has re-emerged in approaches to eradicate HIV infection. A series of modifications of nucle...
Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for...
Interest has re-emerged in approaches to eradicate HIV infection. A series of modifications of nucle...
A family of histone deacetylases (HDACs) mediates chromatin remodeling, and repression of gene expre...
A family of histone deacetylases (HDACs) mediates chromatin remodeling, and repression of gene expre...
Background While antiretroviral therapies have improved life expectancy and reduced viral loads in ...
Resting memory CD4[superscript +] T-cells harboring latent HIV proviruses represent a critical barri...
Histone deacetylases (HDACs) act on histones within the nucleosome-bound promoter of human immunodef...
A reservoir of latently infected memory CD4(+) T cells is believed to be the source of HIV-1 reemerg...
Contains fulltext : 96985.pdf (publisher's version ) (Open Access)A reservoir of l...
Abstract Recently, there is considerable interest in the field of anti-HIV therapy to identify and d...
Silencing of the integrated human immunodeficiency virus type 1 (HIV-1) genome in resting CD4+ T cel...
Objectives: The latent reservoir for HIV-1 in resting memory CD4+ T cells is a major barrier to erad...
© 2014 Elliott et al.Human immunodeficiency virus (HIV) persistence in latently infected resting mem...
<div><p>Resting memory CD4<sup>+</sup> T-cells harboring latent HIV proviruses represent a critical ...
Interest has re-emerged in approaches to eradicate HIV infection. A series of modifications of nucle...
Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for...
Interest has re-emerged in approaches to eradicate HIV infection. A series of modifications of nucle...
A family of histone deacetylases (HDACs) mediates chromatin remodeling, and repression of gene expre...
A family of histone deacetylases (HDACs) mediates chromatin remodeling, and repression of gene expre...
Background While antiretroviral therapies have improved life expectancy and reduced viral loads in ...
Resting memory CD4[superscript +] T-cells harboring latent HIV proviruses represent a critical barri...
Histone deacetylases (HDACs) act on histones within the nucleosome-bound promoter of human immunodef...